Home > Authors > Soumonty Kanungo

Soumonty Kanungo

  • Sun Pharma to acquire skin ailment drug rights from Merck

    Pharma major Sun Pharmaceutical Industries on Wednesday announced that it has entered into an exclusive worldwide licensing agreement with the US-based Merck & Co (known as MSD outside the US and Canada) for the latter's investigational therapeutic antibody candidate tildrakizumab, used for...

    Thursday, 18 September 2014 - 7:30am
  • Lupin in deal to develop product portfolio for Merck

    Agreement can add up to 20 new products to the current portfolio and will cater to 4-5 key therapeutic areas

    Wednesday, 17 September 2014 - 8:00am
  • Cadila Healthcare to take innovator drug to US,Europe markets

    Cadila Healthcare will soon start filings for approval of its innovator drug Lipaglyn in advanced markets such as the US and Europe. The drug has current patients base of 50,000 in India within the first year of its launch.

    Tuesday, 16 September 2014 - 5:20am
  • Form 483 action looms over Sun's Halol plant

    US drug regulator made surprise check last week

    Monday, 15 September 2014 - 7:26am
  • Cadila to take innovator drug to US, Europe markets

    Cadila Healthcare will soon start filings for approval of its innovator drug Lipaglyn in advanced markets such as the US and Europe. The drug has current patients base of 50,000 in India within the first year of its launch.

    Monday, 15 September 2014 - 6:35am
  • Ageing Japan beckons Indian pharma companies

    Though the recent visit of Prime Minister Narendra Modi to Japan ended on a not-so-eventful note for the Indian pharma sector, the industry is hopeful that the Japanese market will slowly turn to India for exports of generics. Japan, which was so far had been a market for patented and innovative...

    Monday, 8 September 2014 - 9:00am
  • E-healthcare start-ups draw venture capitalists, PE funds

    Estimated size of the industry is about Rs 50 crore for the current year with a potential market size to reach Rs 1,000 crore

    Thursday, 4 September 2014 - 5:50am
  • Wockhardt recalls same drug for third time in the US since May

    Drug manufacturer Wockhardt has initiated another round of recall of its high blood pressure drug in the United States after it failed dissolution test. This is the company's third recall of the same drug in the past four months. The recall of 11,661 HDPE (high density polyethylene plastic bottles...

    Monday, 1 September 2014 - 7:44am
  • Fresh drug price control rule may hit Indian pharmaceutical companies

    Move by NPPA to fix prices of more combination drugs hits cos like Ipca Lab, Lupin, Torrent Pharma

    Friday, 29 August 2014 - 5:12am
  • Piramal Healthcare to shut down drug discovery division in Mumbai

    In a move which could put around 150 scientists in a spot, Piramal Healthcare has decided to shut down its drug discovery and Goregaon-based research division in western suburbs of Mumbai.

    Thursday, 28 August 2014 - 12:02am